Benzothiazinethione is a potent preclinical candidate for the treatment of drug-resistant tuberculosis.

MLA

Gao, Chao, et al. “Benzothiazinethione Is a Potent Preclinical Candidate for the Treatment of Drug-Resistant Tuberculosis.” Scientific Reports, July 2016, p. 29717. EBSCOhost, https://doi.org/10.1038/srep29717.

APA

Gao, C., Peng, C., Shi, Y., You, X., Ran, K., Xiong, L., Ye, T., Zhang, L., Wang, N., Zhu, Y., Liu, K., Zuo, W., Yu, L., & Wei, Y. (2016). Benzothiazinethione is a potent preclinical candidate for the treatment of drug-resistant tuberculosis. Scientific Reports, 29717. https://doi.org/10.1038/srep29717

Chicago

Gao, Chao, Cuiting Peng, Yaojie Shi, Xinyu You, Kai Ran, Lu Xiong, Ting-hong Ye, et al. 2016. “Benzothiazinethione Is a Potent Preclinical Candidate for the Treatment of Drug-Resistant Tuberculosis.” Scientific Reports, July, 29717. doi:10.1038/srep29717.